Good Pharmacovigilance Practices (GVP) 2024: Core Principles and Regulatory Requirements
Good Pharmacovigilance Practices (GVP) provide a structured, EU/WHO-aligned quality system for keeping medicines safe—defining oversight roles (MAHs, QPPVs), documentation expectations, and reporting timelines that support consistent benefit–risk decisions. This post explains how GVP turns into daily pharmacovigilance actions like ICSR processing, signal detection, and RMP updates, while highlighting the global cost of medication-related harm and the need for robust, compliant safety systems.